Eton Pharmaceuticals (ETON) Capital Expenditures (2018 - 2025)
Eton Pharmaceuticals' Capital Expenditures history spans 6 years, with the latest figure at $49000.0 for Q4 2025.
- On a quarterly basis, Capital Expenditures rose 308.33% to $49000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $333000.0, a 1180.77% increase, with the full-year FY2025 number at $333000.0, up 1180.77% from a year prior.
- Capital Expenditures hit $49000.0 in Q4 2025 for Eton Pharmaceuticals, down from $284000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for ETON hit a ceiling of $284000.0 in Q3 2025 and a floor of $2000.0 in Q3 2021.
- Historically, Capital Expenditures has averaged $44777.8 across 4 years, with a median of $12000.0 in 2022.
- Biggest five-year swings in Capital Expenditures: tumbled 90.91% in 2021 and later soared 308.33% in 2025.
- Tracing ETON's Capital Expenditures over 4 years: stood at $4000.0 in 2021, then skyrocketed by 200.0% to $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2024, then surged by 308.33% to $49000.0 in 2025.
- Business Quant data shows Capital Expenditures for ETON at $49000.0 in Q4 2025, $284000.0 in Q3 2025, and $12000.0 in Q4 2024.